155 related articles for article (PubMed ID: 19702067)
21. Clinical features, management and outcomes of progressive outer retinal necrosis (PORN) in southern Thailand.
Sittivarakul W; Aui-aree N
J Med Assoc Thai; 2009 Mar; 92(3):360-6. PubMed ID: 19301729
[TBL] [Abstract][Full Text] [Related]
22. Optical coherence tomography of progressive outer retinal necrosis.
Blair MP; Goldstein DA; Shapiro MJ
Retina; 2007; 27(9):1313-4. PubMed ID: 18046245
[No Abstract] [Full Text] [Related]
23. When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.
Kaplan JE; Hanson DL; Cohn DL; Karon J; Buskin S; Thompson M; Fleming P; Dworkin MS;
Clin Infect Dis; 2003 Oct; 37(7):951-8. PubMed ID: 13130408
[TBL] [Abstract][Full Text] [Related]
24. Progressive outer retinal necrosis associated with occlusive vasculitis in acquired immunodeficiency syndrome.
Tseng CC; Chen SN; Hwang JF; Lin CJ; Chen HS
J Formos Med Assoc; 2015 May; 114(5):469-72. PubMed ID: 26002429
[TBL] [Abstract][Full Text] [Related]
25. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
26. [Clinical characteristic and treatment of cytomegalovirus retinitis in 80 patients with acquired immunodeficiency syndrome].
Yang Y; Jiang R; He T; Lu H; Zhang R; Shen Y; Zheng Y; Liu L; Wang W
Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):197-202. PubMed ID: 24841816
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
28. Progression of varicella-zoster virus necrotizing retinopathy in an HIV-negative patient with transient immune deviation.
Lim WK; Chee SP; Nussenblatt RB
Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):607-9. PubMed ID: 15657772
[TBL] [Abstract][Full Text] [Related]
29. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
Mitsuyasu R; Gelman R; Cherng DW; Landay A; Fahey J; Reichman R; Erice A; Bucy RP; Kilby JM; Lederman MM; Hamilton CD; Lertora J; White BL; Tebas P; Duliege AM; Pollard RB;
Arch Intern Med; 2007 Mar; 167(6):597-605. PubMed ID: 17389292
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
31. Progressive outer retinal necrosis: outcomes in the intravitreal era.
Gore DM; Gore SK; Visser L
Arch Ophthalmol; 2012 Jun; 130(6):700-6. PubMed ID: 22801826
[TBL] [Abstract][Full Text] [Related]
32. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
Fagard C; Oxenius A; Günthard H; Garcia F; Le Braz M; Mestre G; Battegay M; Furrer H; Vernazza P; Bernasconi E; Telenti A; Weber R; Leduc D; Yerly S; Price D; Dawson SJ; Klimkait T; Perneger TV; McLean A; Clotet B; Gatell JM; Perrin L; Plana M; Phillips R; Hirschel B;
Arch Intern Med; 2003 May; 163(10):1220-6. PubMed ID: 12767960
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of acute HSV-2 retinal necrosis.
Tran TH; Stanescu D; Caspers-Velu L; Rozenberg F; Liesnard C; Gaudric A; Lehoang P; Bodaghi B
Am J Ophthalmol; 2004 May; 137(5):872-9. PubMed ID: 15126152
[TBL] [Abstract][Full Text] [Related]
34. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
35. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Kunavisarut P; Bijlsma WR; Pathanapitoon K; Patikulsila D; Choovuthayakorn J; Rothova A
Am J Ophthalmol; 2010 Aug; 150(2):218-22. PubMed ID: 20525529
[TBL] [Abstract][Full Text] [Related]
36. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M
HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
[TBL] [Abstract][Full Text] [Related]
37. [Optic neuromyelitis and bilateral acute retinal necrosis due to varicella zoster in a patient with AIDS].
Merle H; Smadja D; Cordoba A
J Fr Ophtalmol; 1998 May; 21(5):381-6. PubMed ID: 9759432
[TBL] [Abstract][Full Text] [Related]
38. Progressive outer retinal necrosis: manifestation of human immunodeficiency virus infection.
Lo PF; Lim R; Antonakis SN; Almeida GC
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25948844
[TBL] [Abstract][Full Text] [Related]
39. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
40. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
